About this trial
After surgery is completed under general anesthesia, extubation is performed after recovery from anesthesia, and during this process, bucking, coughing, and rapid and excessive hemodynamic fluctuations occur very often. These phenomena can lead to high intrathoracic pressure, venous congestion, hematoma formation, or increased bleeding after major neck surgery. (1) They can also increase the risk of aerosol generation, which can transmit infection to health care workers. (2) For this, smooth extubation is required. Methods of administering drugs such as lidocaine, opioids, or dexmedetomidine have been proposed for smooth extubation. (3-5) As a disadvantage, the use of these drugs may be associated with deep sedation and reduced airway reflexes .
Recently, Babu et al. (6) reported that bucking and coughing during extubation could be reduced by changing the timing of administering a muscle relaxant antagonist rather than using these sedative drugs, and thus complications related to extubation could be reduced. In general, in the awakening process, it was common to administer the muscle relaxant at the point of recovery of spontaneous breathing. However, Babu et al. demonstrated the possibility of safe and smooth extubation by changing the timing of administering neostigmine without the use of sedatives or narcotic analgesics, but there are few studies on sugammadex.
Therefore, when recovering from general anesthesia, sugammadex was administered before and immediately after extubation to evaluate and compare smooth extubation (ie, comparison of the frequency of bucking and coughing).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients undergoing general anesthesia for thyroid surgery.
aged between 19 and 64 years
American Society of Anesthesiologists physical status I and II
Disqualifiers
patients with malformation or tumor of the upper respiratory tract
patients with risk of aspiration
obese cases with a BMI > 35
patients in which tracheal intubation was difficult
Trial design
Parallel
Treatments tested in this trial
sugammadex
Drugsugammadex is administered just after extubation
Treatment groups
Trial outcomes
Primary outcomes
extubation quality score
score based on the incidence and severity of coughing straining
Secondary outcomes
time to respiration
time from withdrawal of anesthetics to respiration
time to extubation
time from withdrawal of anesthetics to extubation
sore throat in postanesthetic care unit
Scores obtained by questioning the patient in postanesthetic care unit
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: